Protective effects of caffeic acid phenethyl ester on rotenone-induced myocardial oxidative injury

Pesticide Biochemistry and Physiology

Volumn 82, Issue 3, 2005, Pages 233-239

  Akpinar, Mehmet Beşir ^a   Erdogan, Hasan ^b   Sahin, Semsettin ^b   Ucar, Fatma ^c   Ilhan, Atilla ^a  

^a INONU UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

CAPE; Heart; Lipid; Nitric oxide; Oxidants antioxidants; Peroxidation; Rotenone

Indexed keywords

EID: 20644448596     PISSN: 00483575     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pestbp.2005.03.003     Document Type: Article

References (34)

1. J.J. Jimenez, J.L. Bernal, M.J. del Nozal, M. Novo, M. Higes, and J. Llorente Determination of rotenone residues in raw honey by solid-phase extraction and high-performance liquid chromatography J. Chromatogr. A 871 2000 67 73
2. M. Gosalvez Carcinogenesis with the insecticide rotenone Life Sci. 32 1983 809 816
3. D.J. Talpade, J.G. Greene, D.S. Higgins Jr., and J.T. Greenamyre In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone J. Neurochem. 75 2000 2611 2621
4. V. Bashkatova, M. Alam, A. Vanin, and W.J. Schmidt Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain Exp. Neurol. 186 2004 235 241
5. N. Lapointe, M. St-Hilaire, M.G. Martinoli, J. Blanchet, P. Gould, C. Rouillard, and F. Cicchetti Rotenone induces non-specific central nervous system and systemic toxicity FASEB J. 18 2004 717 719
6. T.B. Sherer, R. Betarbet, A.K. Stout, S. Lund, M. Baptista, A.V. Panov, M.R. Cookson, and J.T. Greenamyre An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J. Neurosci. 22 2002 7006 7015
7. T.B. Sherer, R. Betarbet, C.M. Testa, B.B. Seo, J.R. Richardson, J.H. Kim, G.W. Miller, T. Yagi, A. Matsuno-Yagi, and J.T. Greenamyre Mechanism of toxicity in rotenone models of Parkinson's disease J. Neurosci. 23 2003 10756 10764
8. M. Yagmurca, H. Erdogan, M. Iraz, A. Songur, M. Ucar, and E. Fadillioglu Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats Clin. Chim. Acta 348 2004 27 34
9. - generation in reduction and oxidation cycle of ubiquinones in a model of mitochondrial electron transport systems Biochim. Biophys. Acta 936 1988 377 385
10. Q. Chen, E.J. Vazquez, S. Moghaddas, C.L. Hoppel, and E.J. Lesnefsky Production of reactive oxygen species by mitochondria: central role of complex III J. Biol. Chem. 278 2003 36027 36031
11. G.F. Sud'ina, O.K. Mirzoeva, M.A. Pushkareva, G.A. Korshunova, N.V. Sumbatyan, and S.D. Varfolomeev Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties FEBS Lett. 329 1993 21 24
12. E. Fadillioglu, H. Erdogan, M. Iraz, and M. Yagmurca Effects of caffeic acid phenethyl ester against doxorubicin-induced neuronal oxidant injury Neurosci. Res. Commun. 33 2003 132 138
13. E. Fadillioglu, E. Oztas, H. Erdogan, M. Yagmurca, S. Sogut, M. Ucar, and M.K. Irmak Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats J. Appl. Toxicol. 24 2004 47 52
14. H. Esterbauer, and K.H. Cheeseman Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal L. Packer A.N. Glazer Oxygen radicals in biological systems, methods in enzymology vol. 186 1990 Academic Press California 407 421
15. N.K. Cortas, and N.W. Wakid Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method Clin. Chem. 36 1990 1440 1443
16. Y. Sun, L.W. Oberley, and Y. Li A simple method for clinical assay of superoxide dismutase Clin. Chem. 34 1988 497 500
17. N. Prajda, and G. Weber Malign transformation-linked imbalance: decreased XO activity in hepatomas FEBS Lett. 59 1975 245 249
18. H. Aebi Catalase H.U. Bergmeyer Methods of enzymatic analysis 1974 Academic Press New York and London 673 677
19. O. Lowry, N. Rosenbraugh, L. Farr, and R. Rondall Protein measurement with the folin-phenol reagent J. Biol. Chem. 183 1951 265 275
20. J.G. Zhang, M.A. Tirmenstein, F.A. Nicholls-Grzemski, and M.W. Fariss Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and-independent cell death: protective role of antioxidants Arch. Biochem. Biophys. 393 2001 87 96
21. T. Ide, H. Tsutsui, S. Kinugawa, H. Utsumi, D. Kang, N. Hattori, K. Uchida, K. Arimura, K. Egashira, and A. Takeshita Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium Circ. Res. 85 1999 357 363
22. A. Terzi, M. Iraz, S. Sahin, A. Ilhan, N. Idiz, E. Fadillioglu, Protective effects of erdosteine on rotenone induced oxidant injury in liver tissue, Toxicol. Ind. Health (2005), in press
23. J.J. Lemasters, T. Qian, C.A. Bradham, D.A. Brenner, W.E. Cascio, L.C. Trost, Y. Nishimura, A.L. Nieminen, and B. Herman Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death J. Bioenerg. Biomembr. 31 1999 305 319
24. A.N Murphy, G. Fiskum, and M.F. Beal Mitochondria in neurodegeneration: bioenergetic function in cell life and death J. Cerebr. Blood Flow Metab. 19 1999 231 245
25. K. Yuki, T. Suzuki, S. Katoh, Y. Kakinuma, T. Miyauchi, and Y. Mitsui Endothelin-1 stimulates cardiomyocyte injury during mitochondrial dysfunction in culture Eur. J. Pharmacol. 431 2001 163 170
26. E. Fadillioglu, H. Erdogan, S. Sogut, and I. Kuku The effects of caffeic acid phenethyl ester on DNA-turnover rates and nitric oxide level in doxorubicin-induced myocardial injury T. Klin. J. Med. Sci. 23 2003 366 370
27. M.A. Packer, R. Miesel, and M.P. Murphy Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarization Biochem. Pharmacol. 51 1996 267 273
28. T.S. Song, E.H. Park, G.M. Hur, Y.S. Ryu, Y.S. Lee, J.Y. Lee, Y.M. Kim, and C. Jin Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity Cancer Lett. 175 2002 53 61
29. M.K. Irmak, U. Koltuksuz, N.O. Kutlu, M. Yagmurca, H. Ozyurt, A. Karaman, and O. Akyol The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys Urol. Res. 29 2001 190 193
30. M.K. Irmak, E. Fadillioglu, S. Sogut, H. Erdogan, M. Gulec, M. Ozer, M. Yagmurca, and M.E. Gozukara Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain Cell Biochem. Funct. 26 2003 783 787
31. M.K. Ozer, H. Parlakpinar, and A. Acet Reduction of ischemia-reperfusion induced myocardial infarct size in rats by caffeic acid phenethyl ester (CAPE) Clin. Biochem. 37 2004 702 705
32. H. Okutan, N. Ozcelik, H.R. Yilmaz, and E. Uz Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart Clin. Biochem. 38 2005 191 196
33. H. Ozyurt, S. Sogut, Z. Yildirim, L. Kart, M. Iraz, F. Armutcu, T. Temel, S. Ozen, A. Uzun, and O. Akyol Inhibitory effect of caffeic acid phenethyl ester (CAPE) on bleomycine-induced lung fibrosis in rats Clin. Chim. Acta 339 2004 65 75
34. M. Hosnuter, A. Gurel, O. Babuccu, F. Armutcu, E. Kargi, and A. Isikdemir The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury Burns 30 2004 121 125